ZDHHC9 and familial pancreatic carcinoma: Furthermore, elevated DHHC9 expression was significantly associated with poor clinical outcomes in colorectal cancer, lung adenocarcinoma, gastric cancer, pancreatic cancer and rectal adenocarcinoma (Figure 1H).